Search

Embecta Corp

Cerrado

SectorSanidad

5.13 0.98

Resumen

Variación precio

24h

Actual

Mínimo

5.07

Máximo

5.28

Métricas clave

By Trading Economics

Ingresos

25M

21M

Ventas

50M

272M

P/B

Media del Sector

3.565

56.432

BPA

0.56

Rentabilidad por dividendo

9.31

Margen de beneficios

7.766

Empleados

1,850

EBITDA

17M

62M

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

9.31%

2.27%

Próximas Ganancias

24 nov 2026

Fecha Próximo Dividendo

17 dic 2026

Próxima Fecha de Ex Dividendo

4 dic 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

76M

297M

Apertura anterior

4.15

Cierre anterior

5.13

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

54 / 339 Clasificación en Healthcare

Embecta Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 sept 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 sept 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 sept 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 sept 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 sept 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 sept 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 sept 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 sept 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 sept 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 sept 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 ago 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 ago 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 ago 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

26 ago 2026, 19:36 UTC

Embecta Corp's shares are lower today, continuing a downward trend since Tuesday. Economic data shows persistent inflation, impacting market sentiment.

25 ago 2026, 19:16 UTC

News

Embecta Corp. shares decline amid an announced investigation into potential corporate wrongdoing by Bronstein, Gewirtz & Grossman, LLC. Shares pulled back from earlier session highs.

24 ago 2026, 20:02 UTC

Embecta Corp's shares are lower amid broader market declines, reflecting ongoing geopolitical concerns. No specific company news was identified to explain the movement.

21 ago 2026, 23:02 UTC

Embecta Corp shares are lower in after-market hours, reflecting a decline since Friday's close amid broader market volatility linked to inflation concerns.

20 ago 2026, 19:41 UTC

Embecta Corp shares are higher during Thursday's session, despite an earlier pullback. No specific news was identified to explain the price movement.

19 ago 2026, 23:01 UTC

Embecta Corp shares are lower in after-market trading, having dipped by as much as -1.85% earlier. No specific news was identified for the movement.

18 ago 2026, 19:16 UTC

Embecta Corp's shares are higher during Tuesday's session, reflecting a modest increase since Monday's close amid rising Treasury yields and inflation concerns.

17 ago 2026, 23:41 UTC

Embecta Corp shares are higher in after-market trading, recovering from a recent low and remaining above their 20-day moving average. No specific news was identified.

15 ago 2026, 00:01 UTC

News

Embecta Corp shares are lower in after-market trading amid two class action lawsuits alleging securities fraud and a significant revenue decline.

14 ago 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

13 ago 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting strong gains since Thursday's close and trading above its 20-day moving average.

12 ago 2026, 19:02 UTC

News

Embecta Corp shares are trading lower amid a class action lawsuit alleging securities fraud, following a significant revenue decline and ongoing scrutiny of financial performance.

11 ago 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing recent gains. The stock remains significantly above its 20-day moving average.

10 ago 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market trading amid a securities class action reminder regarding alleged misleading fiscal guidance.

7 ago 2026, 23:31 UTC

Embecta Corp is higher in after-market trading, reflecting positive momentum amid broader market strength and significant gains in major tech stocks.

6 ago 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 ago 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

Comparación entre iguales

Cambio de precio

Embecta Corp previsión

Consenso

By TipRanks

Vender

1 ratings

0

Comprar

0

Mantener

1

Vender

Sentimiento

By Acuity

54 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat